Portfolio Design Labs LLC Buys Shares of 2,085 Synopsys, Inc. $SNPS

Portfolio Design Labs LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,085 shares of the semiconductor company’s stock, valued at approximately $930,000.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Synopsys during the 2nd quarter worth approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Synopsys during the 2nd quarter valued at $747,400,000. Norges Bank acquired a new stake in Synopsys during the 4th quarter valued at $730,197,000. Bank of New York Mellon Corp purchased a new position in Synopsys during the second quarter worth $692,074,000. Finally, State Street Corp raised its holdings in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after acquiring an additional 1,493,912 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

SNPS has been the topic of several recent research reports. Needham & Company LLC restated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Benchmark reiterated a “buy” rating on shares of Synopsys in a research report on Wednesday. Morgan Stanley reduced their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a report on Wednesday. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their target price for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Stifel Nicolaus raised their price target on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $563.59.

View Our Latest Stock Analysis on SNPS

Synopsys Price Performance

SNPS stock opened at $397.92 on Friday. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The stock’s fifty day simple moving average is $420.85 and its 200-day simple moving average is $440.51. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $76.19 billion, a price-to-earnings ratio of 92.11, a price-to-earnings-growth ratio of 2.36 and a beta of 1.23.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the prior year, the firm posted $3.67 earnings per share. The business’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Activity

In related news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.